Cargando…
Activity of antifolates against Pneumocystis carinii dihydrofolate reductase and identification of a potent new agent
The therapy of Pneumocystis carinii (PC) pneumonia is often unsuccessful, particularly in patients with acquired immune deficiency syndrome (AIDS). Because of difficulties in growing the organism in vitro or obtaining purified organisms, current treatment choices have been made with little informati...
Formato: | Texto |
---|---|
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
1987
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2188293/ https://www.ncbi.nlm.nih.gov/pubmed/2950200 |
Ejemplares similares
-
"Neumonitis por pneumocystis carinii" /
por: Ascencio Cortés, Leticia
Publicado: (1996) -
Trimethoprim and other nonclassical antifolates an excellent template for searching modifications of dihydrofolate reductase enzyme inhibitors
por: Wróbel, Agnieszka, et al.
Publicado: (2019) -
Immunization with Pneumocystis carinii A12(1–85) antigen activates immune function against P. carinii
por: Tong, Tong, et al.
Publicado: (2021) -
Molecular epidemiology of Pneumocystis carinii pneumonia.
por: Beard, C B, et al.
Publicado: (1996) -
Characterization of trimethoprim resistant E. coli dihydrofolate reductase mutants by mass spectrometry and inhibition by propargyl-linked antifolates
por: Cammarata, Michael, et al.
Publicado: (2017)